This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
respiratory syndrome | 454 |
infectious bronchitis | 342 |
infected cells | 319 |
amino acid | 279 |
bronchitis virus | 275 |
viral rna | 263 |
rna viruses | 244 |
porcine epidemic | 243 |
acute respiratory | 233 |
epidemic diarrhea | 226 |
virus infection | 215 |
severe acute | 207 |
diarrhea virus | 200 |
porcine reproductive | 193 |
syndrome virus | 185 |
virus replication | 178 |
codon usage | 175 |
nucleocapsid protein | 175 |
vero cells | 173 |
cell culture | 172 |
viral replication | 161 |
spike protein | 157 |
syndrome coronavirus | 157 |
rna synthesis | 157 |
immune response | 145 |
amino acids | 142 |
cleavage sites | 141 |
type i | 137 |
rna virus | 136 |
virus type | 130 |
ck ch | 122 |
human coronavirus | 121 |
immunodeficiency virus | 118 |
antiviral activity | 118 |
human immunodeficiency | 112 |
structural proteins | 112 |
neutralizing antibodies | 110 |
immune responses | 108 |
host cell | 106 |
gene expression | 106 |
like protease | 105 |
reverse transcription | 104 |
cell cycle | 104 |
rna polymerase | 102 |
virus res | 101 |
res doi | 101 |
doc id | 101 |
cord uid | 101 |
cleavage site | 100 |
dengue virus | 98 |
nucleic acid | 97 |
rna replication | 94 |
viral proteins | 92 |
viral infections | 91 |
complete genome | 91 |
clinical signs | 87 |
genomic rna | 87 |
described previously | 86 |
avian infectious | 85 |
vaccinia virus | 84 |
influenza virus | 83 |
transmissible gastroenteritis | 83 |
strand rna | 82 |
porcine apn | 82 |
hepatitis virus | 81 |
open reading | 79 |
st cells | 77 |
viral infection | 77 |
herpes simplex | 76 |
disease virus | 76 |
epithelial cells | 75 |
phylogenetic analysis | 75 |
sars coronavirus | 74 |
genome sequence | 74 |
sequence analysis | 74 |
cell lines | 73 |
coronavirus infectious | 71 |
simplex virus | 71 |
porcine deltacoronavirus | 70 |
viral genome | 66 |
novel coronavirus | 66 |
immune system | 65 |
coronavirus replication | 65 |
mouse hepatitis | 65 |
united states | 65 |
previously described | 65 |
caffeic acid | 65 |
cell surface | 64 |
eif gi | 64 |
binding protein | 64 |
respiratory tract | 64 |
ch ldl | 63 |
i isolate | 63 |
core protein | 62 |
present study | 61 |
dependent rna | 61 |
closely related | 60 |
infectious peritonitis | 60 |
innate immune | 60 |
west nile | 59 |
gastroenteritis virus | 59 |
pedv infection | 59 |
feline infectious | 59 |
respiratory syncytial | 58 |
host cells | 58 |
zika virus | 58 |
monoclonal antibodies | 58 |
highly conserved | 58 |
cell line | 57 |
time rt | 57 |
avian coronavirus | 57 |
nucleotide sequence | 57 |
genetic diversity | 57 |
cells infected | 57 |
like particles | 56 |
well plates | 56 |
recombinant ibvs | 56 |
performed using | 56 |
nile virus | 56 |
reverse transcriptase | 55 |
virus genome | 55 |
fever virus | 54 |
cellular proteins | 54 |
translation initiation | 54 |
middle east | 54 |
like virus | 53 |
prrsv infection | 53 |
feline coronavirus | 53 |
days post | 53 |
syncytial virus | 53 |
i collagen | 53 |
monoclonal antibody | 53 |
fusion protein | 53 |
three times | 52 |
binding domain | 51 |
untranslated region | 51 |
coronavirus spike | 51 |
serum samples | 51 |
nitric oxide | 51 |
reverse genetics | 51 |
cell death | 51 |
newcastle disease | 50 |
pcr products | 49 |
reading frame | 49 |
genome sequences | 49 |
goat anti | 49 |
structural protein | 49 |
stranded rna | 49 |
viral dna | 48 |
secondary structure | 48 |
canine coronavirus | 48 |
east respiratory | 48 |
bovine coronavirus | 48 |
previous studies | 48 |
genbank accession | 47 |
protein synthesis | 47 |
protein expression | 47 |
dna viruses | 47 |
japanese encephalitis | 47 |
rna recombination | 47 |
spike glycoprotein | 47 |
nucleotide sequences | 47 |
mm tris | 47 |
mosaic virus | 47 |
primary monocytes | 46 |
protein gene | 46 |
nonstructural protein | 46 |
like proteinase | 46 |
room temperature | 46 |
small intestine | 46 |
dendritic cells | 46 |
acid sequence | 45 |
tissue culture | 45 |
neutralizing antibody | 45 |
membrane fusion | 45 |
mg ml | 45 |
sense rna | 45 |
results showed | 45 |
transfected cells | 44 |
mdbk cells | 44 |
ms vlps | 44 |
western blot | 44 |
negative control | 43 |
van den | 43 |
total rna | 43 |
genome organization | 43 |
pdcov infection | 42 |
cell cultures | 42 |
terminal domain | 42 |
accessory genes | 41 |
mammalian cells | 41 |
reading frames | 41 |
endoplasmic reticulum | 41 |
mm nacl | 41 |
encephalitis virus | 41 |
may also | 41 |
sg assembly | 41 |
infected individuals | 41 |
chemokine receptor | 41 |
escherichia coli | 41 |
coronavirus genome | 40 |
ch ljl | 40 |
nonstructural proteins | 40 |
cell epitopes | 40 |
infected fetuses | 40 |
important role | 40 |
coding region | 40 |
viral protein | 39 |
nursing pigs | 39 |
bovine serum | 39 |
reverse genetic | 39 |
infectious virus | 38 |
coronavirus infection | 38 |
mouse model | 38 |
initiation factor | 38 |
rna genome | 38 |
virus rna | 38 |
life cycle | 38 |
south korea | 38 |
weaned pigs | 38 |
ch xjyn | 38 |
hbs sirna | 38 |
ibv strains | 38 |
transgenic mice | 37 |
capsid protein | 37 |
recombination events | 37 |
fecal samples | 37 |
homologous recombination | 37 |
vaccine strain | 37 |
results suggest | 37 |
ang ii | 37 |
beaudette strain | 37 |
broadly neutralizing | 36 |
vesicular stomatitis | 36 |
chlorogenic acid | 36 |
canonical cleavage | 36 |
coronavirus disease | 36 |
acid sequences | 35 |
hiv infection | 35 |
binding site | 35 |
hemorrhagic fever | 35 |
molecular epidemiology | 35 |
virus entry | 35 |
family coronaviridae | 35 |
severe pneumonia | 35 |
oxidative stress | 35 |
length genome | 35 |
antibody titers | 35 |
nucleic acids | 35 |
rna silencing | 35 |
molecular biology | 34 |
human cytomegalovirus | 34 |
strain hun | 34 |
prrsv replication | 34 |
analyzed using | 34 |
flow cytometry | 34 |
clinical trials | 34 |
severe covid | 34 |
molecular characterization | 33 |
cell fusion | 33 |
aa identity | 33 |
ibv mass | 33 |
converting enzyme | 33 |
vaccine candidate | 33 |
cd cd | 33 |
virus infections | 33 |
coronavirus nucleocapsid | 32 |
mouse igg | 32 |
canine astvs | 32 |
usage bias | 32 |
taken together | 32 |
coronavirus infections | 32 |
cdna clone | 32 |
also observed | 32 |
sequence identity | 32 |
innate immunity | 32 |
virus strain | 32 |
stress granules | 32 |
coronavirus rna | 32 |
peritonitis virus | 32 |
group iii | 32 |
subgenomic rna | 31 |
murine coronavirus | 31 |
viral genomes | 31 |
dna polymerase | 31 |
bax bak | 31 |
synonymous codon | 31 |
chaperone activity | 31 |
tgev infection | 31 |
infectious diseases | 31 |
human metapneumovirus | 30 |
positive selection | 30 |
protein genes | 30 |
barr virus | 30 |
cycle arrest | 30 |
viral antigens | 30 |
length cdna | 30 |
brome mosaic | 30 |
significant differences | 30 |
inhibitory effect | 30 |
spike proteins | 30 |
gel electrophoresis | 30 |
specific antibodies | 30 |
fusion proteins | 29 |
stomatitis virus | 29 |
signaling pathway | 29 |
cov plpro | 29 |
antiviral effect | 29 |
phylogenetic analyses | 29 |
time pcr | 29 |
total dna | 29 |
fetal bovine | 29 |
avian coronaviruses | 29 |
virus research | 29 |
wild type | 29 |
vaccine strains | 29 |
expression levels | 29 |
genome replication | 29 |
indel pedv | 28 |
sambucus formosananakai | 28 |
phylogenetic trees | 28 |
previous study | 28 |
mutation rates | 28 |
hcv infection | 28 |
cell lysates | 28 |
genomic sequence | 28 |
peripheral blood | 28 |
strand transfer | 28 |
papn wt | 28 |
specific primers | 28 |
statistically significant | 28 |
cov replication | 28 |
restriction sites | 28 |
recombinant viruses | 28 |
time points | 28 |
electron microscopy | 28 |
crystal structure | 28 |
secondary antibody | 28 |
pl pro | 28 |
spike gene | 28 |
virus isolation | 27 |
bronchitis coronavirus | 27 |
pcr product | 27 |
rna chaperone | 27 |
replicase gene | 27 |
infectious cdna | 27 |
respiratory distress | 27 |
even though | 27 |
naturally occurring | 27 |
previously reported | 27 |
ccr expression | 27 |
iii coronaviruses | 27 |
cell entry | 27 |
respiratory disease | 27 |
acid chaperone | 27 |
type prrsv | 27 |
plasma membrane | 27 |
positively selected | 27 |
protein expressed | 27 |
replication cycle | 27 |
type ii | 26 |
viral entry | 26 |
accession numbers | 26 |
results indicated | 26 |
systematic review | 26 |
arteritis virus | 26 |
bacteriophage ms | 26 |
active site | 26 |
expression system | 26 |
embryonated eggs | 26 |
sequence alignment | 26 |
equine arteritis | 26 |
infected cell | 26 |
cdna clones | 26 |
high levels | 26 |
indirect elisa | 26 |
rna binding | 26 |
virus particles | 26 |
respiratory coronavirus | 26 |
culture medium | 26 |
tcid ml | 26 |
heparan sulfate | 26 |
proteolytic processing | 26 |
also found | 26 |
replication complex | 25 |
also known | 25 |
small intestines | 25 |
acid residues | 25 |
binding proteins | 25 |
rna secondary | 25 |
purified using | 25 |
optimal control | 25 |
cdna fragments | 25 |
kda protein | 25 |
human coronaviruses | 25 |
apn transgenic | 25 |
canine parvovirus | 25 |
receptor binding | 25 |
pk cells | 24 |
suckling piglets | 24 |
terminal region | 24 |
viral metagenomics | 24 |
chicken eggs | 24 |
pdcov strains | 24 |
rabies virus | 24 |
rna chaperones | 24 |
independent experiments | 24 |
control group | 24 |
two different | 24 |
virus isolates | 24 |
i interferon | 24 |
infected pigs | 24 |
linked immunosorbent | 24 |
virus discovery | 24 |
like viruses | 24 |
nervous system | 24 |
immune cells | 24 |
vaccine development | 24 |
norwalk virus | 24 |
reference strains | 24 |
pedv strains | 24 |
ljl strain | 24 |
genetic characterization | 24 |
live vaccines | 24 |
virus yield | 24 |
western blotting | 24 |
enveloped viruses | 23 |
dna virus | 23 |
field strains | 23 |
acid constituents | 23 |
order nidovirales | 23 |
growth factor | 23 |
gene sequences | 23 |
avian influenza | 23 |
agarose gel | 23 |
genome regions | 23 |
recent studies | 23 |
host range | 23 |
medium containing | 23 |
humoral immune | 23 |
two major | 23 |
distress syndrome | 23 |
hela cells | 23 |
virus titers | 23 |
dependent translation | 23 |
insect cells | 23 |
prrsv nsp | 23 |
ebola virus | 23 |
viral particles | 23 |
cov clpro | 23 |
immunosorbent assay | 23 |
plaque assay | 23 |
phenolic acid | 23 |
den hoogen | 23 |
washed three | 23 |
porcine nidovirus | 23 |
viral load | 23 |
ldl i | 23 |
central nervous | 22 |
wnv infection | 22 |
significantly higher | 22 |
hbx sirna | 22 |
cell types | 22 |
mm edta | 22 |
trna lys | 22 |
transcription factor | 22 |
large number | 22 |
growth kinetics | 22 |
mrna levels | 22 |
ace receptor | 22 |
cov nsp | 22 |
coronavirus strains | 22 |
type viruses | 22 |
virus nucleocapsid | 22 |
new cpv | 22 |
three independent | 22 |
recombinant proteins | 22 |
unpublished data | 22 |
cov infection | 22 |
pcr amplification | 22 |
antiviral drug | 22 |
target cells | 22 |
primers used | 22 |
human cells | 21 |
human monoclonal | 21 |
yeast two | 21 |
protein interactions | 21 |
dependent manner | 21 |
hypervariable region | 21 |
significantly increased | 21 |
mouth disease | 21 |
infection may | 21 |
coat protein | 21 |
blood samples | 21 |
rna shedding | 21 |
animal models | 21 |
acting elements | 21 |
mass spectrometry | 21 |
coronavirus hku | 21 |
like proteases | 21 |
may play | 21 |
lymph nodes | 21 |
live attenuated | 21 |
cells transfected | 21 |
prrsv antigens | 21 |
defective interfering | 21 |
pedv entry | 21 |
genbank database | 21 |
envelope protein | 21 |
clpro cleavage | 21 |
secondary structures | 21 |
disease severity | 21 |
zika fever | 21 |
recent study | 21 |
recombinant vaccinia | 21 |
eif gii | 21 |
fecal viral | 21 |
cytopathic effect | 21 |
virus capsid | 21 |
protective immunity | 21 |
rna elements | 20 |
stem cell | 20 |
binding domains | 20 |
calculated using | 20 |
inactivated vaccines | 20 |
acting rna | 20 |
virus neutralization | 20 |
rna helicase | 20 |
dna sequence | 20 |
beet yellows | 20 |
silver nanoparticles | 20 |
two distinct | 20 |
genetic analysis | 20 |
stop codon | 20 |
sequence data | 20 |
virus metagenomics | 20 |
authors declare | 20 |
human respiratory | 20 |
virus titer | 20 |
rna molecules | 20 |
also identified | 20 |
lymph node | 20 |
porcine aminopeptidase | 20 |
virus production | 20 |
three different | 20 |
eav nsp | 20 |
like receptor | 20 |
plant viruses | 20 |
antibody responses | 20 |
economic losses | 20 |
heat shock | 20 |
severe diarrhea | 20 |
neutralizing epitopes | 20 |
gene source | 20 |
yellow fever | 20 |
cell monolayer | 20 |
expressed viral | 20 |
spontaneous mutations | 20 |
pcr using | 20 |
yellows virus | 20 |
expressing gp | 20 |
hav orfs | 20 |
plaque formation | 20 |
adaptive immune | 20 |
cleavage products | 20 |
life technologies | 20 |
evolutionary history | 19 |
er stress | 19 |
hotspot mutations | 19 |
north american | 19 |
rna structure | 19 |
strains isolated | 19 |
virus strains | 19 |
virus attachment | 19 |
maximum likelihood | 19 |
murine hepatitis | 19 |
cells expressing | 19 |
vp protein | 19 |
old spf | 19 |
antibody response | 19 |
generation sequencing | 19 |
pp ab | 19 |
loop structure | 19 |
immunofluorescence assay | 19 |
stress response | 19 |
membrane vesicles | 19 |
enteric coronavirus | 19 |
bovine herpesvirus | 19 |
survival factors | 19 |
conserved among | 19 |
pneumonia group | 19 |
cell membrane | 19 |
cell viability | 19 |
nt identity | 19 |
recombination frequency | 19 |
pbs containing | 19 |
cellular protein | 19 |
protein kinase | 19 |
buffered saline | 19 |
inflammatory responses | 19 |
host immune | 19 |
international committee | 19 |
viral diseases | 19 |
sequence homology | 19 |
gnotobiotic pigs | 19 |
recombinant protein | 19 |
host protein | 19 |
cells via | 19 |
chain reaction | 19 |
low ph | 19 |
accession number | 18 |
many viruses | 18 |
black bear | 18 |
coronavirus nl | 18 |
polymerase chain | 18 |
inflammatory cytokines | 18 |
acid changes | 18 |
serially diluted | 18 |
nsp protein | 18 |
viral genomic | 18 |
gastroenteritis coronavirus | 18 |
conjugated goat | 18 |
protein may | 18 |
virus ch | 18 |
hbv infection | 18 |
host factors | 18 |
cell sorting | 18 |
distantly related | 18 |
coronavirus ibv | 18 |
expression plasmid | 18 |
dna sequences | 18 |
proteomic analysis | 18 |
early stages | 18 |
expressing cells | 18 |
di rna | 18 |
phylogenetic tree | 18 |
determined using | 18 |
nt long | 18 |
significant difference | 18 |
alveolar macrophages | 18 |
host translation | 18 |
cultured cells | 18 |
mediated endocytosis | 18 |
gallic acid | 18 |
ace expression | 18 |
infected patients | 18 |
ccr gene | 17 |
induced cell | 17 |
molecular evolution | 17 |
start codon | 17 |
immediately downstream | 17 |
eukaryotic initiation | 17 |
final concentration | 17 |
associated virus | 17 |
expression vectors | 17 |
future studies | 17 |
epidemic diarrhoea | 17 |
experimental infection | 17 |
challenged birds | 17 |
strain vr | 17 |
severe respiratory | 17 |
cells grown | 17 |
proteins involved | 17 |
genomic sequences | 17 |
molecular evolutionary | 17 |
cytopathic effects | 17 |
pdcov strain | 17 |
virus growth | 17 |
stress granule | 17 |
serotype ii | 17 |
glycoprotein gene | 17 |
clinical samples | 17 |
control cells | 17 |
three methods | 17 |
library preparation | 17 |
allantoic fluid | 17 |
phage display | 17 |
blot analysis | 17 |
cov genome | 17 |
aa residues | 17 |
cl pro | 17 |
cellular immune | 17 |
cell movement | 17 |
coronavirus nonstructural | 17 |
signaling pathways | 17 |
joining method | 17 |
i strain | 17 |
natural killer | 17 |
norovirus infection | 17 |
ethanol extract | 17 |
norovirus rdrp | 17 |
catalytic activity | 17 |
critical role | 17 |
coronavirus oc | 17 |
positive control | 17 |
expressing prrsv | 17 |
drug discovery | 17 |
ccr antagonists | 17 |
unknown function | 17 |
washed twice | 16 |
nucleotide identity | 16 |
essential oils | 16 |
natural compounds | 16 |
genetic recombination | 16 |
rna structures | 16 |
preferred codon | 16 |
tested positive | 16 |
natural selection | 16 |
widely used | 16 |
length infectious | 16 |
pcr primers | 16 |
cytokine storm | 16 |
formosananakai extract | 16 |
villous atrophy | 16 |
nursing piglets | 16 |
mrna expression | 16 |
subcellular localization | 16 |
antiviral effects | 16 |
host interactions | 16 |
substrate specificity | 16 |
ibv strain | 16 |
nuclear localization | 16 |
virus diversity | 16 |
orf ab | 16 |
infectious dose | 16 |
tissue tropism | 16 |
selected sites | 16 |
wide range | 16 |
may provide | 16 |
main proteinase | 16 |
initiation complex | 16 |
inactivated virus | 16 |
rna interactions | 16 |
viral envelope | 16 |
key role | 16 |
highly pathogenic | 16 |
investigate whether | 16 |
neutralizing activity | 16 |
determine whether | 16 |
complete genomic | 16 |
spectrum antiviral | 16 |
molecular weight | 16 |
luciferase reporter | 16 |
chronic hepatitis | 16 |
cell responses | 16 |
structural basis | 16 |
two groups | 16 |
virus evolution | 16 |
interfering rna | 16 |
positive cells | 16 |
lactobacillus plantarum | 16 |
infected vero | 16 |
viral pathogenesis | 16 |
clinical symptoms | 16 |
subgenomic rnas | 16 |
comparative analysis | 16 |
virus shedding | 16 |
proteolytic activity | 16 |
co incubator | 16 |
reproductive number | 16 |
replicase proteins | 16 |
two viruses | 16 |
terminal genome | 16 |
neonatal piglets | 16 |
different time | 16 |
pseudorabies virus | 16 |
hong kong | 16 |
antiviral state | 16 |
putative cleavage | 16 |
complex formation | 16 |
potent neutralizing | 16 |
feline coronaviruses | 16 |
initiation factors | 16 |
gp protein | 15 |
experimentally infected | 15 |
genetics analysis | 15 |
see table | 15 |
largest rna | 15 |
type ibv | 15 |
buffer containing | 15 |
complete nucleotide | 15 |
nucleotide changes | 15 |
accessory proteins | 15 |
ccov strains | 15 |
sequence similarity | 15 |
virus genomes | 15 |
monocytes macrophages | 15 |
norovirus rna | 15 |
field isolates | 15 |
two independent | 15 |
host response | 15 |
vaccine virus | 15 |
patients infected | 15 |
specific pathogen | 15 |
genetics system | 15 |
generated using | 15 |
influenza viruses | 15 |
antiviral drugs | 15 |
causative agent | 15 |
pdcov oh | 15 |
annealing reaction | 15 |
induce apoptosis | 15 |
swine fever | 15 |
molecular mass | 15 |
main protease | 15 |
infected monocytes | 15 |
influenza infection | 15 |
mutant viruses | 15 |
rna interference | 15 |
specific antibody | 15 |
cap structure | 15 |
membrane protein | 15 |
viral spike | 15 |
igg antibodies | 15 |
viral pathogens | 15 |
evolutionary genetics | 15 |
online version | 15 |
aa sequences | 15 |
prrsv strains | 15 |
kcal mol | 15 |
viruses isolated | 15 |
analysis showed | 15 |
sambucus nigra | 15 |
cdna synthesis | 15 |
genome analysis | 15 |
replicase polyproteins | 15 |
ns protein | 15 |
receptor ccr | 15 |
first two | 15 |
porcine coronaviruses | 15 |
novel rna | 15 |
recombinant bav | 15 |
dna sequencing | 15 |
genome sequencing | 15 |
vertical transmission | 15 |
ibv isolates | 15 |
first report | 15 |
rna structural | 15 |
point mutations | 15 |
supplementary material | 15 |
early stage | 15 |
highly virulent | 15 |
dna synthesis | 15 |
black bears | 15 |
lymphocyte count | 15 |
virus induces | 15 |
cellular receptor | 15 |
viral life | 15 |
previous reports | 15 |
group ii | 15 |
orally inoculated | 15 |
infection induces | 15 |
gene products | 14 |
stranded dna | 14 |
initiation codon | 14 |
murine norovirus | 14 |
diagnostic methods | 14 |
vero cell | 14 |
applied biosystems | 14 |
human herpesvirus | 14 |
eukaryotic translation | 14 |
challenge virus | 14 |
statistical significance | 14 |
subgenomic mrnas | 14 |
acid substitutions | 14 |
nsp proteinase | 14 |
virus taxonomy | 14 |
genomic regions | 14 |
inhibitory activity | 14 |
natural products | 14 |
conducted using | 14 |
dual sirna | 14 |
clinical disease | 14 |
induce neutralizing | 14 |
metagenomic analysis | 14 |
recombinant virus | 14 |
conserved amino | 14 |
strain ch | 14 |
lysis buffer | 14 |
type strains | 14 |
small molecules | 14 |
multiple sequence | 14 |
sirna expression | 14 |
sars patients | 14 |
cells treated | 14 |
mononuclear cells | 14 |
pcr assay | 14 |
vitro transcription | 14 |
genomic characterization | 14 |
viral genes | 14 |
ibv conn | 14 |
viral translation | 14 |
tgev replication | 14 |
kidney cells | 14 |
type virus | 14 |
gb dna | 14 |
rna folding | 14 |
clinical trial | 14 |
cytokine production | 14 |
mortality rates | 14 |
infected st | 14 |
viral titer | 14 |
deletion mutants | 14 |
gn pigs | 14 |
lactate dehydrogenase | 14 |
directed mutagenesis | 14 |
deltacoronavirus strain | 14 |
porcine savs | 14 |
uninfected cells | 14 |
containing mm | 14 |
rna viral | 14 |
vector control | 14 |
phylogenetic relationships | 14 |
serum albumin | 14 |
virus gene | 14 |
alexa fluor | 14 |
denv infection | 14 |
acid sites | 14 |
nested set | 14 |
cell proliferation | 14 |
essential medium | 14 |
bronchitis viruses | 14 |
tat protein | 14 |
coding regions | 14 |
treated cells | 14 |
cells compared | 14 |
vaccinated animals | 14 |
extraction kit | 14 |
protective effect | 14 |
congo hemorrhagic | 14 |
mortality rate | 14 |
viral shedding | 14 |
inoculated pigs | 14 |
polyacrylamide gel | 14 |
coronavirus nsp | 14 |
genus alphacoronavirus | 14 |
matrix protein | 14 |
disease control | 14 |
common ancestor | 14 |
novel mammalian | 14 |
post infection | 14 |
basic reproductive | 14 |
family kirkoviridae | 14 |
viral rnas | 14 |
delivery system | 14 |
located within | 14 |
bat coronaviruses | 14 |
tcov genome | 14 |
structure probing | 14 |
real time | 14 |
norovirus polymerase | 14 |
cells using | 14 |
studies showed | 14 |
proposed family | 14 |
wd strains | 14 |
diarrhoea virus | 14 |
unfolded protein | 14 |
supplementary data | 13 |
induces apoptosis | 13 |
hcle cells | 13 |
watery eyes | 13 |
homozygous genotype | 13 |
viral mrna | 13 |
putative gene | 13 |
conserved rna | 13 |
ibv infection | 13 |
amniotic fluid | 13 |
pg ml | 13 |
measles virus | 13 |
caribbean region | 13 |
recombinant ibv | 13 |
natural host | 13 |
coronavirus type | 13 |
recent years | 13 |
pabp cleavage | 13 |
genomic dna | 13 |
pv infection | 13 |
reporter gene | 13 |
rna polymerases | 13 |
protease inhibitors | 13 |
glycosylation site | 13 |
modified live | 13 |
first reported | 13 |
ii coronaviruses | 13 |
lung tissues | 13 |
proteins encoded | 13 |
embryonated chicken | 13 |
nuclear factor | 13 |
science foundation | 13 |
sg mrna | 13 |
among different | 13 |
porcine respiratory | 13 |
pedv antigen | 13 |
genes encoding | 13 |
faecal samples | 13 |
deletion mutant | 13 |
nk cells | 13 |
protease cleavage | 13 |
viral replicase | 13 |
infected thp | 13 |
fcwf cells | 13 |
results demonstrated | 13 |
canine respiratory | 13 |
broad spectrum | 13 |
santa cruz | 13 |
new insights | 13 |
vaccinia viruses | 13 |
genetic system | 13 |
disease progression | 13 |
analysis revealed | 13 |
human papillomavirus | 13 |
xjyn strain | 13 |
transcription complex | 13 |
interfering rnas | 13 |
endothelial cells | 13 |
sequence alignments | 13 |
associated coronavirus | 13 |
glycosylation sites | 13 |
cell lysis | 13 |
porcine sav | 13 |
broad range | 13 |
functional receptor | 13 |
pcr assays | 13 |
chickens immunized | 13 |
inactivated vaccine | 13 |
structural genes | 13 |
protease domain | 13 |
tract infections | 13 |
public health | 13 |
serial dilutions | 13 |
vaccine vector | 13 |
better understanding | 13 |
induced apoptosis | 13 |
structural elements | 13 |
labeled bhv | 13 |
recombinant baculovirus | 13 |
nucleocapsid proteins | 13 |
risk factor | 13 |
us swine | 13 |
also detected | 13 |
pro cleavage | 13 |
rna annealing | 13 |
envelope glycoprotein | 13 |
two large | 13 |
octanucleotide sequence | 13 |
inflammatory response | 13 |
current study | 13 |
sequence comparison | 13 |
binding sites | 13 |
incubation period | 13 |
primer pairs | 13 |
well tissue | 13 |
bmv rna | 13 |
health organization | 13 |
world health | 13 |
different viral | 13 |
single cell | 13 |
permissive mdbk | 13 |
labeled goat | 13 |
cohort study | 13 |
results indicate | 13 |
movement protein | 13 |
amplified using | 13 |
strain respprrs | 13 |
specific cd | 13 |
high mortality | 12 |
elevating virus | 12 |
novo initiation | 12 |
contains two | 12 |
new viruses | 12 |
also revealed | 12 |
cowden strain | 12 |
i ifn | 12 |
parainfluenza virus | 12 |
another study | 12 |
ge healthcare | 12 |
selection pressure | 12 |
porcine nidoviruses | 12 |
infected mice | 12 |
gene end | 12 |
sambucus formosana | 12 |
rna sequences | 12 |
neutralization assay | 12 |
several studies | 12 |
relationships among | 12 |
using primers | 12 |
ibv types | 12 |
protective immune | 12 |
prrsv strain | 12 |
canine astv | 12 |
crucial role | 12 |
expression vector | 12 |
european countries | 12 |
papn dvii | 12 |
retrospective cohort | 12 |
expressing porcine | 12 |
cell apoptosis | 12 |
infection induced | 12 |
viral families | 12 |
ml streptomycin | 12 |
protein cleavage | 12 |
horseradish peroxidase | 12 |
foreign genes | 12 |
ribavirin treatment | 12 |
blood mononuclear | 12 |
turkey coronavirus | 12 |
gene start | 12 |
prrsv genome | 12 |
common cold | 12 |
following infection | 12 |
coronavirus replicase | 12 |
light chain | 12 |
serine proteases | 12 |
nidovirus replication | 12 |
viral growth | 12 |
bat covs | 12 |
herpesvirus type | 12 |
proteolytic cleavage | 12 |
mini kit | 12 |
functional significance | 12 |
located upstream | 12 |
visualized using | 12 |
complete sequence | 12 |
positive samples | 12 |
one virus | 12 |
protective efficacy | 12 |
watery diarrhea | 12 |
human rhinovirus | 12 |
venezuelan equine | 12 |
two clusters | 12 |
studies revealed | 12 |
significantly reduced | 12 |
virucidal activity | 12 |
necrosis factor | 12 |
asymptotically stable | 12 |
reactive oxygen | 12 |
wnv core | 12 |
assay using | 12 |
viral gene | 12 |
plant virus | 12 |
acute lung | 12 |
us pdcov | 12 |
cells released | 12 |
analysis using | 12 |
leukemia virus | 12 |
classical swine | 12 |
control measures | 12 |
primer trna | 12 |
kna ccov | 12 |
ml penicillin | 12 |
oxygen species | 12 |
kindly provided | 12 |
fecal virus | 12 |
internal control | 12 |
entire genome | 12 |
protein bands | 12 |
lower respiratory | 12 |
genome structure | 12 |
ms vlp | 12 |
results obtained | 12 |
aa substitutions | 12 |
driven migration | 12 |
rna genomes | 12 |
virus dna | 12 |
feline macrophages | 12 |
first strand | 12 |
localization signal | 12 |
mainland china | 12 |
drug repurposing | 12 |
mrna transcription | 12 |
trypsin treatment | 12 |
immune evasion | 12 |
mitochondrial pathway | 12 |
antiviral agents | 12 |
small intestinal | 12 |
transmembrane domain | 12 |
gst pull | 12 |
specific igg | 12 |
mock control | 12 |
docking score | 12 |
treated groups | 12 |
permissive hmlu | 12 |
novel human | 12 |
purification kit | 12 |
protein binds | 12 |
risk factors | 12 |
type infection | 12 |
group i | 12 |
van der | 12 |
airway epithelial | 12 |
distilled water | 12 |
genus deltacoronavirus | 12 |
high affinity | 12 |
data associated | 12 |
culture supernatant | 12 |
genetic variant | 12 |
dna replication | 12 |
chiba virus | 12 |
protein complex | 12 |
viral proteinases | 12 |
proximal apn | 11 |
zinc finger | 11 |
genetic stability | 11 |
culture media | 11 |
consensus sequence | 11 |
obtained using | 11 |
based secondary | 11 |
culture plates | 11 |
functional characterization | 11 |
angiotensin ii | 11 |
recombinant lactobacillus | 11 |
viruses including | 11 |
cleavage assay | 11 |
also showed | 11 |
inhibitory effects | 11 |
bovine adenovirus | 11 |
pigs inoculated | 11 |
drosophila melanogaster | 11 |
vitro ligation | 11 |
virus species | 11 |
pdcov rna | 11 |
binding affinity | 11 |
loop region | 11 |
biological functions | 11 |
protection conferred | 11 |
death receptor | 11 |
purifying selection | 11 |
gene showed | 11 |
reticulocyte lysate | 11 |
tumor necrosis | 11 |
study using | 11 |
seven novel | 11 |
mutant virus | 11 |
den boon | 11 |
rsv infection | 11 |
may affect | 11 |
detected using | 11 |
related viruses | 11 |
much lower | 11 |
pcr reaction | 11 |
isosteric replacement | 11 |
condition iv | 11 |
protein response | 11 |
pairing interactions | 11 |
polyacrylamide gels | 11 |
ch lsc | 11 |
family proteins | 11 |
cycle progression | 11 |
coronavirus main | 11 |
broiler chickens | 11 |
ns gene | 11 |
pregnant sows | 11 |
ibv genome | 11 |
small interfering | 11 |
stem ethanol | 11 |
translation shutoff | 11 |
inflammatory cells | 11 |
leader sequence | 11 |
state university | 11 |
coronavirus papain | 11 |
dengue viruses | 11 |
therapeutic agents | 11 |
time point | 11 |
intrinsic mitochondrial | 11 |
hpv infection | 11 |
mouse proximal | 11 |
lung epithelial | 11 |
results suggested | 11 |
serine protease | 11 |
melatonin treatment | 11 |
bootstrap values | 11 |
cysteine protease | 11 |
first step | 11 |
gp fusion | 11 |
results demonstrate | 11 |
rna molecule | 11 |
seven recombinant | 11 |
severe clinical | 11 |
respiratory viral | 11 |
den worm | 11 |
strand cdna | 11 |
protein encoded | 11 |
may lead | 11 |
crystal structures | 11 |
rna extraction | 11 |
clinical features | 11 |
astv strains | 11 |
interferon response | 11 |
treated group | 11 |
like superfamily | 11 |
mice orally | 11 |
among sars | 11 |
stunt virus | 11 |
structure prediction | 11 |
sequencing analysis | 11 |
pedv infections | 11 |
viruses may | 11 |
genome size | 11 |
fowlpox virus | 11 |
nidovirus infection | 11 |
small molecule | 11 |
furin cleavage | 11 |
mouse anti | 11 |
old embryonated | 11 |
conformational changes | 11 |
culture supernatants | 11 |
virus expressing | 11 |
samples collected | 11 |
bmv rnas | 11 |
complete genomes | 11 |
envelope proteins | 11 |
recombinant nc | 11 |
biochemical assays | 11 |
luciferase activity | 11 |
cardiac glycosides | 11 |
dengue hemorrhagic | 11 |
cellular translation | 11 |
coronavirus avian | 11 |
human population | 11 |
tris ph | 11 |
purified protein | 11 |
mesenchymal stem | 11 |
different types | 11 |
protein nsp | 11 |
potential use | 11 |
nh cl | 11 |
encoded proteinases | 11 |
intergenic region | 11 |
replicative organelles | 11 |
mrna synthesis | 11 |
tagged nsp | 11 |
bmv cp | 11 |
takes place | 11 |
basic amino | 11 |
high degree | 11 |
goose parvovirus | 11 |
reproduction number | 11 |
noncoding region | 11 |
pigs infected | 11 |
novel viruses | 11 |
mass virus | 11 |
virus world | 11 |
standard deviations | 11 |
associated protein | 11 |
replication complexes | 11 |
lung injury | 11 |
lsc i | 11 |
cal viruses | 11 |
identified using | 11 |
viral titers | 11 |
apn promoter | 11 |
chemokine receptors | 11 |
infected host | 11 |
ill patients | 11 |
von brunn | 11 |
maternal antibodies | 11 |
terminal deletion | 11 |
delivery platform | 11 |
potential role | 11 |
viral membrane | 11 |
capture elisa | 11 |
pcr analysis | 11 |
molecular cloning | 11 |
base pairs | 11 |
constructed using | 11 |
mammalian cell | 11 |
primer extension | 11 |
nsp nsp | 11 |
replication transcription | 11 |
genetic systems | 11 |
cress dna | 11 |
attenuated live | 11 |
capsid proteins | 11 |
etiological agent | 11 |
ha protein | 11 |
coding sequences | 11 |
villous enterocytes | 11 |
rescued viruses | 10 |
bootstrap replicates | 10 |
polymerase activity | 10 |
like proteinases | 10 |
cai values | 10 |
cervical cancer | 10 |
whole genome | 10 |
symptomatic wnv | 10 |
using method | 10 |
aa changes | 10 |
peritoneal macrophages | 10 |
huh cells | 10 |
plnc domain | 10 |
conjugated anti | 10 |
template switching | 10 |
synchronized cells | 10 |
mrna vaccine | 10 |
amersham biosciences | 10 |
strain ck | 10 |
new virus | 10 |
genome characterization | 10 |
per ml | 10 |
reported previously | 10 |
effective vaccines | 10 |
genome expression | 10 |
genotype vii | 10 |
restriction enzyme | 10 |
aldosterone system | 10 |
viral sequences | 10 |
virus challenge | 10 |
blood pressure | 10 |
investigated whether | 10 |
per se | 10 |
primer set | 10 |
two novel | 10 |
also used | 10 |
different viruses | 10 |
infected dams | 10 |
base pair | 10 |
plasmid pfbav | 10 |
norovirus replication | 10 |
isolate i | 10 |
potent inhibitor | 10 |
cov rna | 10 |
acidic ph | 10 |
mice inoculated | 10 |
quantitative real | 10 |
recombination event | 10 |
genetic clusters | 10 |
significantly decreased | 10 |
contact exposed | 10 |
subgenomic mrna | 10 |
conn viruses | 10 |
mail address | 10 |
skim milk | 10 |
data suggest | 10 |
respiratory virus | 10 |
virus isolate | 10 |
viral diversity | 10 |
virus families | 10 |
kwd strains | 10 |
ics assay | 10 |
economically important | 10 |
dependent enhancement | 10 |
progeny virus | 10 |
canine coronaviruses | 10 |
domain vii | 10 |
high concentrations | 10 |
nd nd | 10 |
two overlapping | 10 |
heterogenous hvrs | 10 |
neurological bear | 10 |
well plate | 10 |
different times | 10 |
potent antiviral | 10 |
four structural | 10 |
cold pbs | 10 |
crystal violet | 10 |
winter moth | 10 |
virus ns | 10 |
formosana nakai | 10 |
examined using | 10 |
intestinal contents | 10 |
poultry industry | 10 |
sodium dodecyl | 10 |
mass viruses | 10 |
primer binding | 10 |
better understand | 10 |
genetic distance | 10 |
detect antibodies | 10 |
first identified | 10 |
rna pseudoknot | 10 |
fold dilutions | 10 |
antiviral immunity | 10 |
may contribute | 10 |
single domain | 10 |
viral attachment | 10 |
immediately upstream | 10 |
sg mrnas | 10 |
transmembrane domains | 10 |
virion assembly | 10 |
log ge | 10 |
coronavirus genomes | 10 |
mutation rate | 10 |
intensive care | 10 |
virus may | 10 |
polyclonal antibody | 10 |
angiotensin system | 10 |
ribosome entry | 10 |
material table | 10 |
expression plasmids | 10 |
stem cells | 10 |
viral antigen | 10 |
host cellular | 10 |
apn transgene | 10 |
vp gene | 10 |
fold serial | 10 |
significant economic | 10 |
different genotypes | 10 |
human cd | 10 |
deep sequencing | 10 |
prrsv gp | 10 |
cells well | 10 |
rad expressing | 10 |
tcid assay | 10 |
restriction enzymes | 10 |
will provide | 10 |
also confirmed | 10 |
vaccine design | 10 |
purified recombinant | 10 |
protein induces | 10 |
data suggested | 10 |
pedv rna | 10 |
specific iga | 10 |
vitro cleavage | 10 |
maximum parsimony | 10 |
swab samples | 10 |
domain antibodies | 10 |
significant increase | 10 |
culture infectious | 10 |
virus stocks | 10 |
ec values | 10 |
simple method | 10 |
cell tropism | 10 |
virus disease | 10 |
mock infected | 10 |
human populations | 10 |
equine encephalitis | 10 |
method described | 10 |
pulmonary fibrosis | 10 |
chimeric intron | 10 |
cells may | 10 |
mediated lysis | 10 |
pedv isolate | 10 |
lactic acid | 10 |
cyclization sequences | 10 |
factors involved | 10 |
taq dna | 10 |
internal ribosome | 10 |
molecular analysis | 10 |
signal peptide | 10 |
virus vaccine | 10 |
necrosis virus | 10 |
membrane structures | 10 |
genome composition | 10 |
technical assistance | 10 |
surface expression | 10 |
restriction site | 10 |
polymerase gene | 10 |
rescued virus | 10 |
virus stock | 10 |
coding sequence | 10 |
error bars | 10 |
cov cdna | 10 |
putative orfs | 10 |
porcine alveolar | 10 |
loaded onto | 10 |
first time | 10 |
critically ill | 10 |
mammalian viruses | 10 |
parental strains | 10 |
viral disease | 10 |
ribosomal frameshifting | 10 |
di rnas | 10 |
species transmission | 10 |
poorly understood | 10 |
conventional weaned | 10 |
conventional pigs | 10 |
pedv strain | 10 |
gc content | 10 |
rna templates | 10 |
spf chickens | 10 |
humoral immunity | 10 |
mem containing | 10 |
serotype i | 10 |
reference sequence | 10 |
pedv replication | 10 |
increased risk | 10 |
hospitalized patients | 10 |
deduced amino | 10 |
persistent infection | 10 |
two hmpv | 10 |
stranded positive | 10 |
drug development | 10 |
new genus | 10 |
respiratory pathogens | 10 |
i interferons | 10 |
mycophenolic acid | 10 |
minimum essential | 10 |
different steps | 10 |
three replicates | 10 |
virus isolated | 10 |
fecal shedding | 10 |
parental virus | 10 |
gene editing | 10 |
respiratory infections | 10 |
molecular mechanisms | 10 |
parental strain | 10 |
done using | 10 |
mass type | 10 |
highly divergent | 10 |
mk cells | 10 |
antiviral response | 10 |
mm dishes | 10 |
dendritic cell | 10 |
potential anti | 9 |
specific inhibition | 9 |
web server | 9 |
newly discovered | 9 |
putative trs | 9 |
sindbis virus | 9 |
various times | 9 |
panhandle formation | 9 |
pfu ml | 9 |
cytokine chemokine | 9 |
viral clearance | 9 |
ibv beaudette | 9 |
mm mgcl | 9 |
human monocytic | 9 |
study showed | 9 |
southern china | 9 |
incubated overnight | 9 |
supports bat | 9 |
cell protein | 9 |
enc values | 9 |
length rna | 9 |
virus spike | 9 |
ii strains | 9 |
endemic equilibrium | 9 |
sequence positions | 9 |
viral loads | 9 |
stat activation | 9 |
partially purified | 9 |
antibody binding | 9 |
pcr detection | 9 |
study reported | 9 |
cdna ends | 9 |
us porcine | 9 |
rna motifs | 9 |
antigenic sites | 9 |
highly contagious | 9 |
plantarum nc | 9 |
human monocytes | 9 |
ccr deficiency | 9 |
inactivated fetal | 9 |
ephemeral fever | 9 |
site mutations | 9 |
antiviral compounds | 9 |
see section | 9 |
coronavirus replicative | 9 |
live vaccine | 9 |
partial protection | 9 |
vaccine candidates | 9 |
regulatory sequence | 9 |
pdb id | 9 |
total number | 9 |
mutational analysis | 9 |
basic proteins | 9 |
containing fbs | 9 |
proteolytic activation | 9 |
helper virus | 9 |
hmpv clusters | 9 |
phosphate buffered | 9 |
protease activity | 9 |
inflammatory cytokine | 9 |
neutralization tests | 9 |
ion torrent | 9 |
important roles | 9 |
exposed birds | 9 |
porcine enteric | 9 |
replicase complex | 9 |
infected nursing | 9 |
i ii | 9 |
animals inoculated | 9 |
functional domains | 9 |
ray crystallography | 9 |
mrna decay | 9 |
yellows closterovirus | 9 |
tissue samples | 9 |
virus nonstructural | 9 |
small envelope | 9 |
coomassie brilliant | 9 |
wild birds | 9 |
viral polymerase | 9 |
well conserved | 9 |
poliovirus infection | 9 |
findings suggest | 9 |
different cell | 9 |
mean enc | 9 |
internal initiation | 9 |
strains vr | 9 |
data obtained | 9 |
cruz biotechnology | 9 |
neutralization test | 9 |
barley protoplasts | 9 |
san diego | 9 |
cell receptor | 9 |
protein levels | 9 |
pcr results | 9 |
including sars | 9 |
virus culture | 9 |
central role | 9 |
possible role | 9 |
previously shown | 9 |
hart park | 9 |
two weeks | 9 |
adcml assay | 9 |
study performed | 9 |
using recombinant | 9 |
rights reserved | 9 |
citrus tristeza | 9 |
aligned using | 9 |
cell immune | 9 |
plasmid pbav | 9 |
relatively low | 9 |
using mega | 9 |
gallus gallus | 9 |
also contain | 9 |
substitutions per | 9 |
coronaviridae family | 9 |
infectious clone | 9 |
winter dysentery | 9 |
cellular membranes | 9 |
orf encodes | 9 |
th passage | 9 |
pk structure | 9 |
sequence analyses | 9 |
adenovirus type | 9 |
relative synonymous | 9 |
domain antibody | 9 |
virus detection | 9 |
high frequency | 9 |
statistical analyses | 9 |
kda polypeptide | 9 |
polyclonal antisera | 9 |
viral components | 9 |
surface display | 9 |
protein spots | 9 |
family members | 9 |
strains including | 9 |
three groups | 9 |
infection ccr | 9 |
cov replicons | 9 |
muench method | 9 |
per bird | 9 |
corresponding author | 9 |
hbx gene | 9 |
metagenomic sequencing | 9 |
coronavirus mouse | 9 |
discontinuous transcription | 9 |
viral metagenomic | 9 |
highly basic | 9 |
chikungunya virus | 9 |
independent manner | 9 |
induced tgf | 9 |
ribosome recycling | 9 |
equal amounts | 9 |
old conventional | 9 |
sirna molecules | 9 |
previously published | 9 |
viral myocarditis | 9 |
predicted cleavage | 9 |
antiviral innate | 9 |
population size | 9 |
green fluorescent | 9 |
virus date | 9 |
remains unclear | 9 |
bone marrow | 9 |
deltacoronavirus supports | 9 |
pcr reactions | 9 |
rapid detection | 9 |
also reported | 9 |
animal health | 9 |
virus viability | 9 |
potent anti | 9 |
one hand | 9 |
peplomer protein | 9 |
current evidence | 9 |
primer pair | 9 |
two additional | 9 |
respiratory diseases | 9 |
elispot assay | 9 |
new coronavirus | 9 |
severe disease | 9 |
coronavirus defective | 9 |
cell signaling | 9 |
previous results | 9 |
chaperone properties | 9 |
terminal part | 9 |
successfully isolated | 9 |
cd cells | 9 |
lysosomotropic agents | 9 |
liver failure | 9 |
secreted protein | 9 |
acid rearrangements | 9 |
cek cells | 9 |
sequence conservation | 9 |
like particle | 9 |
pigs orally | 9 |
fluorescent protein | 9 |
may contain | 9 |
survival rate | 9 |
polyclonal anti | 9 |
old weaned | 9 |
apoptosis induced | 9 |
deduced aa | 9 |
binding region | 9 |
diabetes mellitus | 9 |
porcine torovirus | 9 |
cancer cells | 9 |
factor receptor | 9 |
bacterial artificial | 9 |
mm imidazole | 9 |
rapid amplification | 9 |
avian pneumovirus | 9 |
nucleotide sequencing | 9 |
coronavirus gene | 9 |
immunofluorescence staining | 9 |
major structural | 9 |
different regions | 9 |
protein sequences | 9 |
viral mrnas | 9 |
lymphocyte proliferation | 9 |
previously identified | 9 |
days later | 9 |
may represent | 9 |
care unit | 9 |
panherpesvirus pcr | 9 |
lelystad virus | 9 |
bovine ephemeral | 9 |
inflammatory drugs | 9 |
transmission dynamics | 9 |
partial sequences | 9 |
recovered viruses | 9 |
nucleotide substitutions | 9 |
bp fragment | 9 |
ic values | 9 |
times higher | 9 |
positions coded | 9 |
indicated times | 9 |
human antibody | 9 |
natural science | 9 |
nucleotide composition | 9 |
direct contact | 9 |
breda virus | 9 |
ms ms | 9 |
overlapping orfs | 9 |
gene transfer | 9 |
occurring compounds | 9 |
bd biosciences | 9 |
naturally infected | 9 |
virus classification | 9 |
also shown | 9 |
viral capsid | 9 |
least two | 9 |
infectious rna | 9 |
basic reproduction | 9 |
equal volume | 9 |
recombination among | 9 |
mutation frequency | 9 |
rs protein | 9 |
transgenic mouse | 9 |
medium supplemented | 9 |
virus infectivity | 9 |
master mix | 9 |
antigenic cross | 9 |
brilliant blue | 9 |
receptor expression | 9 |
nt sequences | 8 |
inoculated piglets | 8 |
recombinant fusion | 8 |
regulatory factor | 8 |
virus core | 8 |
serial passage | 8 |
chickens vaccinated | 8 |
cov helicase | 8 |
control sirna | 8 |
genetic variability | 8 |
forest virus | 8 |
differences among | 8 |
mean values | 8 |
immune signaling | 8 |
armored rna | 8 |
pig farms | 8 |
strains circulating | 8 |
mediated immune | 8 |
hybrid system | 8 |
vee virus | 8 |
embryonating eggs | 8 |
possibly due | 8 |
fluorescence microscopy | 8 |
lesion scores | 8 |
seems likely | 8 |
draft genome | 8 |
branch lengths | 8 |
viral particle | 8 |
cellular receptors | 8 |
mouse monoclonal | 8 |
targeted rna | 8 |
polyprotein processing | 8 |
kor knu | 8 |
fc receptor | 8 |
therapeutic potential | 8 |
cell activation | 8 |
hbv genome | 8 |
differentially expressed | 8 |
denaturing conditions | 8 |
using specific | 8 |
replication efficiency | 8 |
swine testicular | 8 |
neutralizing epitope | 8 |
acid bacteria | 8 |
transcription regulatory | 8 |
also show | 8 |
performed according | 8 |
trizol reagent | 8 |
coronavirus associated | 8 |
clinical course | 8 |
antiviral activities | 8 |
dodecyl sulfate | 8 |
gene silencing | 8 |
considered significant | 8 |
conserved sequence | 8 |
acid usage | 8 |
exact test | 8 |
recombinant infectious | 8 |
luciferase activities | 8 |
recombinant avian | 8 |
cc chemokine | 8 |
ng ml | 8 |
flaviviridae family | 8 |
total rnas | 8 |
tristeza virus | 8 |
gastrointestinal tract | 8 |
sialic acid | 8 |
genome encodes | 8 |
driving force | 8 |
single amino | 8 |
parental viruses | 8 |
complete orf | 8 |
sg construct | 8 |
causes severe | 8 |
three additional | 8 |
cp binding | 8 |
family picornaviridae | 8 |
messenger rna | 8 |
virtual screening | 8 |
site year | 8 |
enteric disease | 8 |
sialic acids | 8 |
active form | 8 |
drug targets | 8 |
magnetic resonance | 8 |
mhv mutants | 8 |
observed among | 8 |
operophtera brumata | 8 |
treated birds | 8 |
dependent collagen | 8 |
baculovirus expression | 8 |
cd binding | 8 |
increasing concentrations | 8 |
ptov strains | 8 |
major capsid | 8 |
fold higher | 8 |
region may | 8 |
lymphoid tissue | 8 |
secondary antibodies | 8 |
relatively conserved | 8 |
type mice | 8 |
chicken flocks | 8 |
usage patterns | 8 |
might also | 8 |
coumaric acid | 8 |
age groups | 8 |
blood monocytes | 8 |
two types | 8 |
pathogenic viruses | 8 |
vascular endothelial | 8 |
inoculated orally | 8 |
rtgev vectors | 8 |
multiple functions | 8 |
conserved domains | 8 |
conserved domain | 8 |
mouse serum | 8 |
clinical outcomes | 8 |
prostate cancer | 8 |
large amounts | 8 |
chaperone activities | 8 |
among patients | 8 |
chicken embryos | 8 |
relatedness values | 8 |
biological significance | 8 |
point mutation | 8 |
saudi arabia | 8 |
signal transduction | 8 |
graphpad prism | 8 |
essential role | 8 |
infection inhibition | 8 |
yeast display | 8 |
infectious clones | 8 |
newly emerged | 8 |
abi prism | 8 |
murine leukemia | 8 |
evidence suggests | 8 |
strain yn | 8 |
may increase | 8 |
three recombinant | 8 |
cytokine responses | 8 |
germinal centers | 8 |
protein facilitates | 8 |
borne flaviviruses | 8 |
trimerization motif | 8 |
ibv field | 8 |
extracted using | 8 |
mouse secondary | 8 |
cellular factors | 8 |
studies using | 8 |
mrna translation | 8 |
untreated cells | 8 |
fusion peptide | 8 |
purified nsp | 8 |
provide protection | 8 |
local strains | 8 |
attenuated vaccine | 8 |
intestinal epithelial | 8 |
feline enteric | 8 |
negative controls | 8 |
korean wd | 8 |
analyses based | 8 |
mechanical ventilation | 8 |
constant control | 8 |
vectored vaccines | 8 |
human airway | 8 |
core proteins | 8 |
infectious disease | 8 |
differential equations | 8 |
mass strain | 8 |
results confirmed | 8 |
randomly selected | 8 |
nsp cleavage | 8 |
receptor signaling | 8 |
nuclear magnetic | 8 |
codon adaptation | 8 |
old specific | 8 |
pantropic canine | 8 |
escape mutants | 8 |
cellular vimentin | 8 |
laboratory animal | 8 |
ethidium bromide | 8 |
clinical specimens | 8 |
plasmid dna | 8 |
human norovirus | 8 |
fatal disease | 8 |
substitutions site | 8 |
alternative orfs | 8 |
molecular mechanism | 8 |
sites within | 8 |
previous work | 8 |
sequence encoding | 8 |
animal coronaviruses | 8 |
rna sequence | 8 |
cpv strains | 8 |
effective number | 8 |
porcine kidney | 8 |
porcine coronavirus | 8 |
gene encoding | 8 |
like receptors | 8 |
orally immunized | 8 |
estimating fifty | 8 |
genomic analysis | 8 |
hcov nl | 8 |
long distance | 8 |
expression systems | 8 |
clinical evidence | 8 |
sars cov | 8 |
pg equivalent | 8 |
papn di | 8 |
isolate knu | 8 |
rnase iii | 8 |
may result | 8 |
swine farms | 8 |
th th | 8 |
large rna | 8 |
coronavirus genera | 8 |
gb virus | 8 |
small basic | 8 |
measured using | 8 |
terminal repeat | 8 |
genome length | 8 |
retrospective study | 8 |
positive sense | 8 |
proteinase cleavage | 8 |
using methods | 8 |
cell survival | 8 |
viral evolution | 8 |
ribosomal subunit | 8 |
igg antibody | 8 |
usage preferences | 8 |
long terminal | 8 |
lactogenic immunity | 8 |
increased expression | 8 |
inflammatory mediators | 8 |
rna accumulation | 8 |
virus glycoprotein | 8 |
commonly used | 8 |
assay showed | 8 |
glass slides | 8 |
least one | 8 |
specific siga | 8 |
left panel | 8 |
serial passages | 8 |
virus life | 8 |
host genetic | 8 |
also contains | 8 |
neutralizing titer | 8 |
antiviral properties | 8 |
virus vector | 8 |
pneumonia groups | 8 |
genome contains | 8 |
aa identities | 8 |
factor eif | 8 |
induces cell | 8 |
pcr purification | 8 |
utr rna | 8 |
successfully used | 8 |
vaccinated chickens | 8 |
steady state | 8 |
multiple sclerosis | 8 |
showed increased | 8 |
based assays | 8 |
high titers | 8 |
evolutionary processes | 8 |
class i | 8 |
rhvr i | 8 |
american type | 8 |
times post | 8 |
killer cells | 8 |
mem supplemented | 8 |
vectors expressing | 8 |
protein inhibits | 8 |
scaffold morphing | 8 |
severe critical | 8 |
cutoff value | 8 |
bound antibodies | 8 |
subsequent studies | 8 |
virulent strain | 8 |
one study | 8 |
traditional chinese | 8 |
log tcid | 8 |
th cells | 8 |
presenting cells | 8 |
using trizol | 8 |
acute diarrhea | 8 |
strand switching | 8 |
guinea pigs | 8 |
utr rnas | 8 |
cal type | 8 |
using real | 8 |
semliki forest | 8 |
neonatal pigs | 8 |
data using | 8 |
decoy epitope | 8 |
full length | 8 |
sequence similarities | 8 |
significantly lower | 8 |
terminal rna | 8 |
nl replication | 8 |
antigenic differences | 8 |
treg cells | 8 |
evasion strategy | 8 |
foreign gene | 8 |
mebus strain | 8 |
ibv reference | 8 |
acting element | 8 |
poliovirus rna | 8 |
recently reported | 8 |
genetic variants | 8 |
animal model | 8 |
proteinase activity | 8 |
dinucleotide frequencies | 8 |
acid differences | 8 |
pathogen free | 8 |
structure elements | 8 |
molecular probes | 8 |
acid positions | 8 |
next generation | 8 |
lamina propria | 8 |
similar results | 8 |
translation kinetics | 8 |
maintenance medium | 8 |
reporter assay | 7 |
elisa using | 7 |
convalescent patients | 7 |
gene analysis | 7 |
diagnostic laboratory | 7 |
using vero | 7 |
like pedv | 7 |
kilodalton polypeptide | 7 |
reporter genes | 7 |
cell monolayers | 7 |
beneficial effects | 7 |
also supported | 7 |
herpes virus | 7 |
assays using | 7 |
affinity chromatography | 7 |
animal rhabdoviruses | 7 |
cell permeability | 7 |
virus subgenomic | 7 |
see supplementary | 7 |
field isolate | 7 |
tumor cells | 7 |
currently recognized | 7 |
highly similar | 7 |
sirna duplexes | 7 |
mitochondrial apoptosis | 7 |
sample buffer | 7 |
proteomics analysis | 7 |
specific primer | 7 |
rabbit igg | 7 |
analysis confirmed | 7 |
recombinant rmna | 7 |
airway inflammation | 7 |
strain kor | 7 |
eif alpha | 7 |
remains unknown | 7 |
genomic rnas | 7 |
mm dtt | 7 |
ii viruses | 7 |
viral glycoproteins | 7 |
old gn | 7 |
nv gene | 7 |
codon bias | 7 |
hela cell | 7 |
cellular responses | 7 |
aa long | 7 |
recombinant adenoviruses | 7 |
conserved region | 7 |
polypeptide encoded | 7 |
gi cleavage | 7 |
ibv sequences | 7 |
based biosensor | 7 |
chaperone proteins | 7 |
tissue dna | 7 |
restriction fragment | 7 |
human health | 7 |
ursus americanus | 7 |
ptov strain | 7 |
cells following | 7 |
approximately kda | 7 |
enzyme ace | 7 |
taiwan strains | 7 |
genome packaging | 7 |
strain ita | 7 |
host gene | 7 |
vitro inhibition | 7 |
three novel | 7 |
like strains | 7 |
dimensional structure | 7 |
structure predictions | 7 |
qiaamp viral | 7 |
cell attachment | 7 |
encoding gene | 7 |
infectious bursal | 7 |
acid annealing | 7 |
bars represent | 7 |
pivotal role | 7 |
coronaviruses including | 7 |
inhibitory concentration | 7 |
genomic composition | 7 |
genomic organization | 7 |
two times | 7 |
herpesvirus infection | 7 |
template rna | 7 |
virus antigen | 7 |
competing interests | 7 |
based vaccine | 7 |
neutralizing antigenicity | 7 |
human covs | 7 |
research institute | 7 |
catalytic triad | 7 |
major role | 7 |
reaction conditions | 7 |
codon sites | 7 |
potential drug | 7 |
pdcov antigen | 7 |
bear herpesviruses | 7 |
calf serum | 7 |
protein assay | 7 |
porcine circovirus | 7 |
ita zoid | 7 |
infected animals | 7 |
adhesion molecule | 7 |
protein translation | 7 |
evolutionary relationships | 7 |
viral genetic | 7 |
antigenic variants | 7 |
rpmi medium | 7 |
mutation pressure | 7 |
heart failure | 7 |
protein level | 7 |
effective antiviral | 7 |
fragment encoding | 7 |
antiviral responses | 7 |
crossover sites | 7 |
protein produced | 7 |
final extension | 7 |
protective effects | 7 |
acute infection | 7 |
vitro replication | 7 |
protein concentrations | 7 |
using flow | 7 |
infection results | 7 |
conjugated secondary | 7 |
respiratory illness | 7 |
gel extraction | 7 |
disease caused | 7 |
may help | 7 |
ccr antagonist | 7 |
multiple comparison | 7 |
medicinal plants | 7 |
rna titers | 7 |
specific mab | 7 |
enzymatic activity | 7 |
specific cell | 7 |
commercially available | 7 |
critical category | 7 |
cell transplantation | 7 |
approved drugs | 7 |
hun displayed | 7 |
permissive cells | 7 |
asian leopard | 7 |
hybridoma cells | 7 |
protein binding | 7 |
cytomegalovirus infection | 7 |
ribosomal subunits | 7 |
fusion gene | 7 |
comparison tests | 7 |
conserved across | 7 |
first described | 7 |
infected marc | 7 |
virus polymerase | 7 |
plant species | 7 |
gene sequence | 7 |
lavage administration | 7 |
cloned cdna | 7 |
recombinant strains | 7 |
detection program | 7 |
allantoic cavities | 7 |
different geographic | 7 |
primary antibody | 7 |
moderate category | 7 |
hunov rdrp | 7 |
genetic factors | 7 |
mediated cleavage | 7 |
genome cyclization | 7 |
protein interaction | 7 |
protein induced | 7 |
viral structural | 7 |
flag antibody | 7 |
factor alpha | 7 |
nsp interaction | 7 |
viral protease | 7 |
infected pams | 7 |
mediated apoptosis | 7 |
invertebrate viruses | 7 |
swine infertility | 7 |
target genes | 7 |
canine astroviruses | 7 |
dipeptidyl peptidase | 7 |
several viruses | 7 |
eukaryotic cells | 7 |
zinc fingers | 7 |
dnase i | 7 |
viruses associated | 7 |
infectious titer | 7 |
single nucleotide | 7 |
genetic material | 7 |
corona virus | 7 |
structural studies | 7 |
may occur | 7 |
df cells | 7 |
serially propagated | 7 |
lymphoid tissues | 7 |
right side | 7 |
approximately kb | 7 |
samples using | 7 |
host proteins | 7 |
hepatitis delta | 7 |
primary antibodies | 7 |
cloning vector | 7 |
efficient replication | 7 |
chaperoning activity | 7 |
synthesized using | 7 |
standard deviation | 7 |
secretory pathway | 7 |
following hcov | 7 |
control strategies | 7 |
arkansas type | 7 |
molecule inhibitors | 7 |
acute liver | 7 |
virus infected | 7 |
monocytic cell | 7 |
culture collection | 7 |
porcine serum | 7 |
chain variable | 7 |
left side | 7 |
gene duplication | 7 |
dengue fever | 7 |
virus propagation | 7 |
late stages | 7 |
erad tuning | 7 |
also included | 7 |
extreme end | 7 |
serum sample | 7 |
recognition site | 7 |
field viruses | 7 |
complementary sequences | 7 |
porcine enterocytes | 7 |
replicase polyprotein | 7 |
coli bj | 7 |
cysteine proteases | 7 |
genome complexity | 7 |
virus proteins | 7 |
national natural | 7 |
i genome | 7 |
per site | 7 |
alv treatment | 7 |
cell response | 7 |
using human | 7 |
negative serum | 7 |
data indicate | 7 |
drug designing | 7 |
first detected | 7 |
synthetic peptides | 7 |
molecular docking | 7 |
putative rna | 7 |
side effects | 7 |
upper respiratory | 7 |
genetic heterogeneity | 7 |
subgenomic promoter | 7 |
destabilizing activity | 7 |
protein vp | 7 |
envelope glycoproteins | 7 |
secreting cells | 7 |
rectal swab | 7 |
clustered together | 7 |
new ptov | 7 |
target cell | 7 |
monophyletic group | 7 |
empty vector | 7 |
research program | 7 |
web version | 7 |
sequence reads | 7 |
potent broadly | 7 |
functional analysis | 7 |
thank dr | 7 |
stimulated genes | 7 |
adjoint system | 7 |
anova followed | 7 |
hubei province | 7 |
protease inhibitor | 7 |
higher levels | 7 |
family reoviridae | 7 |
encodes four | 7 |
control pk | 7 |
antiviral treatment | 7 |
old pigs | 7 |
containing trypsin | 7 |
vitro assays | 7 |
death signaling | 7 |
epitope mapping | 7 |
booster immunization | 7 |
granule formation | 7 |
diarrhea viruses | 7 |
dominant selection | 7 |
quantitative analysis | 7 |
two genotypes | 7 |
biochemical characterization | 7 |
globally asymptotically | 7 |
located immediately | 7 |
cleavage activity | 7 |
bile acids | 7 |
length genomes | 7 |
codon substitution | 7 |
drug design | 7 |
viral transcription | 7 |
cytoplasmic tail | 7 |
current knowledge | 7 |
bursal disease | 7 |
exogenous protease | 7 |
canine astrovirus | 7 |
drug resistance | 7 |
known rna | 7 |
feline calicivirus | 7 |
enterovirus serotypes | 7 |
gain insight | 7 |
potential antiviral | 7 |
cellular rna | 7 |
calculated according | 7 |
four genera | 7 |
bronchitis coronaviruses | 7 |
enterovirus infections | 7 |
infectious progeny | 7 |